No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial

Abstract

ClinicalTrials.gov, http://clinicaltrials.gov/, NCT01465438.